v3.25.1
Basis of Presentation (Details Narrative) - USD ($)
3 Months Ended
Jan. 23, 2025
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Subsidiary, Sale of Stock [Line Items]        
Cash   $ 4,586,389   $ 406,408
Accumulated deficit   243,925,693   $ 237,819,806
Working capital   5,400,000    
Cash used in operating activities   1,117,422 $ 3,616,793  
Net loss   6,105,887 $ 2,853,806  
Number of shares issued   $ 2,086,592    
Series A Common Warrant [Member]        
Subsidiary, Sale of Stock [Line Items]        
Exercise price of warrant $ 20.00      
IPO [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of shares issued $ 553,846      
Proceeds from issuance public offering $ 9,000,000.0      
IPO [Member] | Series A Common Warrant [Member]        
Subsidiary, Sale of Stock [Line Items]        
Number of warrants issued 1      
Exercise price of warrant $ 20.00